课题基金 / 基金详情

The Role of TSC Genes During Brain Development

The Role of TSC Genes During Brain Development
TSC 基因在大脑发育过程中的作用
批准号:
8075009
负责人:
KEVIN C ESS
金额:
$16.56万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-06-15 至 2012-05-31

项目摘要

项目成果

KEVIN C ESS的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):本提案的目标是:1)确定TSC基因用于控制神经前体细胞中神经元和神经胶质细胞的生成的机制;2)确定这些过程中的缺陷如何导致结节性硬化症复合体(TSC)中的皮质畸形。TSC是由TSC1或TSC2基因突变引起的,是癫痫和自闭症最常见的遗传原因。这些特征很可能是由于几乎所有患者都能发现的皮质脑畸形(结节)所致。以前的工作已经证明了结节内严重的板层破坏,有异常的神经胶质细胞,畸形的神经元,以及表达神经元和神经胶质标记的“巨细胞”。这些发现表明,TSC基因在特定神经元群体的产生以及神经前体细胞从神经元向神经胶质细胞的转换过程中发挥着关键作用。通常控制这一过程的机制还不是很清楚,但似乎与细胞周期退出和G1的长度有关。细胞增殖、细胞周期总长度和G1期由细胞周期蛋白、细胞周期蛋白依赖性蛋白激酶(Cdk)和cdk抑制物如p27kip1(P27)调节。值得注意的是,尽管TSC1或TSC2缺陷的成纤维细胞p27的水平和活性降低,但在TSC1或TSC2缺陷的神经前体细胞中还没有类似的变化的报道。我们的具体目标是:1)确定TSD基因在神经前体细胞产生神经元和神经胶质细胞的时间上的作用;2)确定7sc1缺陷神经前体细胞的G1期和增殖;3)确定7sc7缺陷神经前体细胞中p27的表达、亚细胞定位和功能。我们将通过在体内和体外研究7sc1缺陷的神经前体细胞来实现这些目标。这些神经前体细胞的分化能力将通过谱系特异性标记来确定。此外,我们将使用S时相示踪剂来测量具有TSC1缺陷神经前体细胞的小鼠的细胞周期长度、G1期持续时间以及活跃增殖的细胞比例。最后,将确定p27的表达、亚细胞定位和功能。候选人将利用K08奖,通过与他的导师范德比尔特大学神经科学研究社区的互动,以及与发育神经生物学的国内和国际领导者的积极参与,获得发育神经生物学方面的专业知识。总体而言,这一奖项应该会让他成为一名独立的内科科学家,成功地竞争未来NIH的外部资金。相关:结节性硬化症(TSC)是一种遗传性疾病,其表现包括癫痫、脑肿瘤、自闭症和发育迟缓。这一建议试图了解异常神经前体细胞在TSC中的作用。这些发现可能对患有TSC的个体以及患有癫痫障碍和自闭症的非TSC患者具有广泛的治疗意义。
英文摘要
DESCRIPTION (PROVIDED BY APPLICANT): The goals of this proposal are to 1) define mechanisms used by the TSC genes to control the generation of neurons and then glia from neural progenitor cells and 2) determine how defects in these processes result in cortical malformations in Tuberous Sclerosis Complex (TSC). TSC is caused by mutation of either the TSC1 or TSC2 genes and is the most common genetic cause of epilepsy and autism. These features are very likely due to cortical brain malformations (tubers) that are found in almost all patients. Previous work has demonstrated severe laminar disruptions within tubers with abnormal glia, dysmorphic neurons, and "giant" cells expressing neuronal as well as glia markers. These findings suggest that the TSC genes play a critical role during the generation of specific neuronal populations as well as the switch from neuronal to glia production by neural progenitor cells. Mechanisms that normally control this process are not well understood but appear linked to cell cycle exit and the length of G1. Proliferation, total cell cycle length, and G1 duration are mediated by cyclins, cyclin-dependent kinases (cdk), and cdk inhibitors such as p27kip1 (p27). Notably, while Tsc1 or Tsc2-deficient fibroblasts have decreased levels and activity of p27, similar alterations in Tsc1 or Tsc2-deficient neural progenitor cells have not been reported. Our Specific Aims are: 1) Determine the role of the Tsd gene on the timing of neuronal and glia production from neural progenitor cells, 2) determine G1 duration and proliferation in 7sc1-deficient neural progenitor cells, and 3) determine p27 expression, subcellular localization, and function in 7sc7-deficient neural progenitor cells. We will achieve these aims by studying 7sc1-deficient neural progenitor cells both in vivo and in vitro. The ability of these neural progenitor cells to differentiate will be determined using lineage specific markers. In addition, we will use S phase tracers to measure cell cycle length, G1 duration, and the proportion of cells that are actively proliferating in mice with Tsc1-deficient neural progenitor cells. Finally, p27 expression, subcellular localization, and function will be determined. The candidate will utilize this K08 Award to gain expertise in developmental neurobiology though interactions with his mentor, the Neuroscience research community at Vanderbilt University, and active involvement with national and international leaders in Developmental Neurobiology. Overall, this award should position him to become an independent physician-scientist who will successfully compete for future extramural NIH funding. Relevance: Tuberous Sclerosis Complex (TSC) is a genetic disease whose manifestations include seizure disorders, brain tumors, autism and developmental delay. This proposal seeks to understand the role of abnormal neural progenitor cells to TSC. These findings will likely have broad therapeutic implications for individuals with TSC as well as non-TSC patients with seizure disorders and autism.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1371/journal.pone.0124649
发表时间: 2015
期刊: PloS one
影响因子: 3.7
作者: [Grier MD, Carson RP, Lagrange AH]
通讯作者: Lagrange AH
DOI: 10.1016/j.bbr.2015.05.045
发表时间: 2015-09-15
期刊: BEHAVIOURAL BRAIN RESEARCH
影响因子: 2.7
作者: [Grier, Mark D., Carson, Robert P., Lagrange, Andre H.]
通讯作者: Lagrange, Andre H.
DOI: 10.1097/wco.0b013e32832c4ff5
发表时间: 2010-04-01
期刊: CURRENT OPINION IN NEUROLOGY
影响因子: 4.8
作者: [Ess, Kevin C.]
通讯作者: Ess, Kevin C.
DOI: 10.1016/j.nbd.2011.08.024
发表时间: 2012-01
期刊: NEUROBIOLOGY OF DISEASE
影响因子: 6.1
作者: [Carson, Robert P., Van Nielen, Dominic L., Winzenburger, Peggy A., Ess, Kevin C.]
通讯作者: Ess, Kevin C.
Identifying mTOR Dependent Periods During Brain Development
  • 批准号:
    10352829
  • 项目类别:
  • 资助金额:
    $6.67万
  • 财政年份:
    2021
  • 负责人:
    KEVIN C ESS
  • 依托单位:
Identifying mTOR Dependent Periods During Brain Development
  • 批准号:
    10442566
  • 项目类别:
  • 资助金额:
    $38.32万
  • 财政年份:
    2020
  • 负责人:
    KEVIN C ESS
  • 依托单位:
Identifying mTOR Dependent Periods During Brain Development
  • 批准号:
    10054882
  • 项目类别:
  • 资助金额:
    $39.76万
  • 财政年份:
    2020
  • 负责人:
    KEVIN C ESS
  • 依托单位:
Drug development for tuberous sclerosis complex and other pediatric epileptogenic diseases using neurovascular and cardiac microphysiological models
  • 批准号:
    10174287
  • 项目类别:
  • 资助金额:
    $114.29万
  • 财政年份:
    2020
  • 负责人:
    KEVIN C ESS
  • 依托单位:
海外基金